Skip to main content
. 2015 Dec 15;127(7):938–947. doi: 10.1182/blood-2015-09-671834

Figure 1.

Figure 1

Cumulative incidence of GVHD. (A) Acute GVHD II-IV. Cumulative incidence of grade II-IV acute GVHD in recipients of haploidentical donor, unrelated donor with ATG, and unrelated donor without ATG allo-HCT (overall, P = .07). (B) Chronic GVHD. Cumulative incidence of chronic GVHD in recipients of haploidentical donor, unrelated donor with ATG, and unrelated donor without ATG allo-HCT (overall, P < .001 at 1 year and 2 years).